Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants
- 1 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (8) , 1939-1942
- https://doi.org/10.1016/j.bmcl.2004.01.078
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Inhibitors of hepatitis C virus NS3·4A protease 2. Warhead SAR and optimizationBioorganic & Medicinal Chemistry Letters, 2004
- Inhibitors of hepatitis C virus NS3·4A protease 1. Non-Charged tetrapeptide variantsBioorganic & Medicinal Chemistry Letters, 2003
- Acyl sulfonamides as potent protease inhibitors of the hepatitis C virus full-Length NS3 (Protease-Helicase/NTPase): A comparative study of different C-terminalsBioorganic & Medicinal Chemistry, 2003
- Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?Expert Opinion on Investigational Drugs, 2003
- 5 Inhibitors of Hepatitis C Virus NS3•4A Protease: An Overdue Line of TherapyProgress in Medicinal Chemistry, 2002
- Solution and solid-Phase synthesis of potent inhibitors of hepatitis C Virus NS3 proteinaseBioorganic & Medicinal Chemistry Letters, 2001
- Acyclic analogs of kainoids: Their syntheses and depolarizing activitiesTetrahedron, 1996
- 1,4-Addition of secondary and tertiary alkylzinc bromides to .alpha.,.beta.-unsaturated ketones without a copper catalyst.Journal of the American Chemical Society, 1995
- Synthesis of homochiral R-Baclofen from S-glutamic acid.Tetrahedron: Asymmetry, 1992
- A new route to sulfonium ylides. Diphenylsulfonium isopbopylideTetrahedron Letters, 1967